This Could Be the First Cannabis-Derived Drug to Win FDA Approval
Epidiolex shows great promise in relieving two severe forms of epilepsy.
Epidiolex shows great promise in relieving two severe forms of epilepsy.
His fentanyl overdose came from counterfeit Vicodin, and he likely didn't know what he was ingesting.
The latest data underline the folly of tackling the "opioid crisis" by restricting access to pain pills.
Harvard economist Jeffrey Miron explains why taking out cartel kingpins demonstrates the folly of prohibition.
He faces a reelection challenge from the left, with Cynthia Nixon running on criminal justice issues like pot legalization.
The FDA chief's mixed, moderate record has surprised both his champions and his critics.
Federal prosecutors didn't need more leverage against drug offenders, but they're going to get it anyway.
Donald Trump's deal with Senator Cory Gardner could pave the way for the effective elimination of the federal law banning marijuana in those states that have legalized pot under state law.
Drug war is over (if you want it).
Contrary to what many supporters of legalization seem to think, prisons are not overflowing with pot smokers busted for possession.
He's doing it for the vets. And probably for the potential new customer base.
Under the final rule, pharmacists may fill high-dose opioid prescriptions as long as they verify them.
Surgeon General Adams says "Research shows that when naloxone and overdose education are available to community members, overdose deaths decrease in those communities."
"The situation in the market is pretty dire," one major cannabis seller told us.
Plus: Hackers take over Atlanta, demand ransom to lift lock on city computers.
We just may have finally reached the last of the line in this fabled family.
A homegrown hemp renaissance could be just around the corner.
The best part: It's a documentary.
Taking a cue from the CDC, the proposed regulation imposes an arbitrary cap on opioid prescriptions.
"We all are so optimistic that industrial hemp can become sometime in the future what tobacco was in Kentucky's past."
The challenge for libertarians is to explain that you don't get all the good stuff without having certain institutions, ideas, and temperaments in place.
The Trump administration starts negotiations on drug sentencing with a harsh opening bid.
The president's anti-opioid plan is heavy on tactics that have already failed.
But a new bill could change that.
A study suggests that easier access to the overdose-reversing medication encourages opioid use.
The photographer's long history of substance abuse predates her OxyContin prescription by more than four decades.
Since responses to pain treatment vary widely, it is hazardous to draw broad conclusions from a single study.
Somebody tell the president.
The government's efforts to get between people and the drugs they want have not prevented drug use, but they have made it more dangerous.
Our best hope is that commercial and cultural change will overcome the tendency to force top-down, one-size-fits-all solutions onto complicated problems.
The cop's boss says he did nothing wrong; the local D.A. disagrees.
"The governor's office does not want to hear this bill....The state police do not want to hear this bill," committee chairman explains behind closed doors.
If drug dealers have blood on their hands, so do drug warriors.
The war on drugs looks crueler by the day.
Making drug-company shareholders foot the bill for a public health crisis is flaky and counterproductive.
Our top federal law enforcement officer has no idea what real pain is really like-or what doctors do to manage it.
The current regime makes it hard for licensed cannabusinesses to compete with the black market.
El Paso Democrat, trying to change Texas from red to blue, talks about guns, weed, and how we've already got "record safety and security on our border"
The president has never encountered a problem he can't imagine solving with violence.
There's little discussion of the war on drugs at the Conservative Political Action Conference. Howard Wooldridge wants to change that.
The Drug Policy Alliance's Maria McFarland Sánchez-Moreno talks about her new book.
It's all a matter of the suddenly important "security clearance."
Restricted distribution is a barrier to generic competition.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10